Isolated lung perfusion with tumor necrosis factor for pulmonary metastases

This publication has 17 references indexed in Scilit:

• Lung perfusion with chemotherapy in patients with unresectable metastatic sarcoma to the lung or diffuse bronchioloalveolar carcinoma
  The Journal of Thoracic and Cardiovascular Surgery, 1995
• Isolated lung perfusion with tumor necrosis factor: A swine model in preparation of human trials
  The Annals of Thoracic Surgery, 1994
• Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms.
  Journal of Clinical Investigation, 1992
• High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
  Journal of Clinical Oncology, 1992
• Pharmacokinetics and toxicity of isolated perfusion of lung with doxorubicin
  Journal of Surgical Research, 1991
• The pattern of lung injury induced after pulmonary exposure to tumor necrosis factor-α depends on the route of administration
  Diagnostic Microbiology and Infectious Disease, 1990
• Mechanisms of pulmonary edema induced by tumor necrosis factor-alpha.
  Circulation Research, 1990
• Effect of interferon-γ and tumor necrosis factor on the expression of class I and class II major histocompatibility molecules by cultured human umbilical vein endothelial cells
  Cellular Immunology, 1988
• Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon
  Nature, 1985
• Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells.
  The Journal of Experimental Medicine, 1985